SAGIMET BIOSCIENCES ANNOUNCES FIRST PATIENT DOSED IN AURORA PHASE 3 U.S. CLINICAL TRIAL OF DENIFANSTAT FOR MODERATE TO SEVERE ACNE

Reuters · 3d ago

Please log in to view news